Clinical Trial Update: Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer [Phase 2]

View source ↗

Summary

The update indicates that a Phase 2 neoadjuvant trial of Leucoselect Phytosome for early-stage lung cancer (I–II) has been terminated, with results posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Leucoselect Phytosome

Snippet

Sponsor: VA Office of Research and Development | Conditions: Early Stage Lung Cancer (I and II) | Phase 2 | Status: TERMINATED | Results posted: 2026-02-17